Novel charged sodium and calcium channel inhibitor active against neurogenic inflammation

  1. Seungkyu Lee
  2. Sooyeon Jo
  3. Sébastien Talbot
  4. Han-Xiong Bear Zhang
  5. Masakazu Kotoda
  6. Nick A Andrews
  7. Michelino Puopolo
  8. Pin W Liu
  9. Thomas Jacquemont
  10. Maud Pascal
  11. Laurel M Heckman
  12. Aakanksha Jain
  13. Jinbo Lee
  14. Clifford J Woolf  Is a corresponding author
  15. Bruce P Bean  Is a corresponding author
  1. Boston Children's Hospital, United States
  2. Harvard Medical School, United States
  3. Université de Montréal, Canada
  4. Renaissance School of Medicine at Stony Brook University, United States
  5. Sage Partner International, United States
10 figures, 1 table and 2 additional files

Figures

State dependent inhibition of Cav2.2 channels by the neutral compound NNCB-2.

(A) Time course of inhibition of Cav2.2 current by external NNCB-2 applied at concentrations from 3 to 100 µM. Current carried by 5 mM Ba2+ was evoked by 50-millisecond steps from −70 to +10 mV …

State dependent inhibition of Cav2.2 channels by the charged compound CNCB-2.

(A) Time course of inhibition of Cav2.2 current by external CNCB-2 applied at concentrations from 10 to 300 µM. Current carried by 5 mM Ba2+ current was evoked by 50-millisecond steps from −70 to …

Test of whether Cav2.2 inhibition by NNCB-2 and CNCB-2 requires channel opening and comparison of internal and external application of CNCB-2 .

(A) Calcium channel inhibition by NNCB-2 or CNCB-2 does not require channel opening. Ba2+ current was elicited in a whole-cell recording by 50-millisecond steps from −70 to + 10 mV delivered every …

Dose-dependent inhibition of native N-type Ca2+ channels in mouse sympathetic neurons by CNCB-2 applied extracellularly.

(A) Time course of inhibition by 10 µM CNCB-2. Current carried by 5 mM Ba2+ was evoked by 50 ms steps from −70 to +10 mV delivered every 3 s. The external solution contained 5 μM nimodipine to block …

CNCB-2 applied extracellularly inhibits Nav1.7 sodium channels.

(A) Time course of inhibition by 3 µM CNCB-2. Current was evoked by 10 ms steps from −70 to 0 mV delivered every 5 s. Mean ± SEM, n = 5. (B) Inhibition by 3 µM CNCB-2 at different holding …

Use-dependent inhibition of Nav1.7 sodium channels by externally-applied CNCB-2 compared to lidocaine and bupivacaine.

(A) Inhibition of Nav1.7 current by 3 µM CNCB-2 applied with stimulation at 0.1 Hz (20-msec depolarizations from −100 mV to 0 mV) for two minutes followed by two minutes of stimulation at 10 Hz, a …

Inhibition of action potential generation in mouse DRG neurons by CNCB-2.

(A) Action potential firing evoked by injections of 40 pA, 150 pA, and 200 pA in a small-diameter mouse DRG neuron before and after 5 min exposure to 3 µM CNCB-2. Resting potential in CNCB-2 was …

Inhibition of TTX-resistant sodium current in mouse DRG neurons by CNCB-2.

(A) Time-course of inhibition of TTX-resistant sodium current in a small mouse DRG neuron by 3 µM CNCB-2. TTX-resistant sodium current was isolated by solutions containing 300 nM TTX. Current was …

Effect of CNCB-2 in mouse pain models.

(A) Inhibition of paw withdrawal in paw incision model of post-operative pain. Threshold for response to von Frey filaments tested 1, 4 and 8 hr after injection of CNCB-2 into an injured paw 24 hr …

Inhibition of CGRP release and neurogenic lung inflammation by NNCB-2 and CNCB-2.

(A) Effect of 30 µM NNCB-2 or 30 µM CNCB-2 on release of CGRP induced by application of 50 mM KCl to DRG cultures (p=0.15 for 30 µM NNCB-2 (n = 4) compared to 50 mM KCl with no drug (n = 4), p=0.028 …

Tables

Key resources table
Reagent typeDesignationSource or referenceIdentifiersAdditional
information
Strain (Mus musculus)Swiss Webster CFWCharles RiverCat#024
Strain (Mus musculus)C57BL6/JJackson Lab000664
Strain (Mus musculus)BALB/cJackson Lab001026
Cell linerat Cav2.2 tsA201 cell linePMID: 15201306Line #201719Dr. Diane Lipscombe, Brown University
Cell linehuman Nav1.7 HEK cell linePMID: 22442564Dr. Sooyeon Jo,
Harvard Medical School
AntibodyFITC anti-mouse CD45BD BiosciencesCat 553079
RRID:AB_394609
AntibodyPR anti-mouse Siglec-FBD BiosciencesCat 552126
RRID:AB_394341
AntibodyAPC anti-mouse GR-1Thermo FisherCat
17-5931-81
RRID:AB_469475
AntibodyPE-Cy7 anti-mouse CD3eThermo FisherCat 25-0031-81
RRID:AB_469571
AntibodyPerCP anti-mouse F4/80BiolegendCat 123125
RRID:AB_893495
Commercial assay or kitMycoAlert PLUS Mycoplasma Detection KitLonzaLT07-703
Commercial assay or kitRat CGRP Enzyme Immunoassay KitBertin Pharma/Cayman Chemical#589001
Chemical compoundNNCB-2 (3-Cyclopentylmethylsulfanyl-2-(3,3-dimethyl-butylamino)-N-(4-methoxy-benzyl)-propionamide)This paperSynthesized by Sundia MediTech, structure verified by NMR and mass spectrometry.
Chemical compoundCNCB-2 ([2-Cyclopentylmethylsulfanyl-1-(4-methoxy-benzylcarbamoyl)-ethyl]−(3,3-dimethyl-butyl)-dimethyl-ammonium; chloride salt)This paperSynthesized by Sundia MediTech, structure verified by NMR and mass spectrometry.
Chemical compoundPapainWorthington BiochemicalLS003126
Chemical compoundCollagenase Type ISigma10103578001
Chemical compoundDispase Type IISigma4942078001
Chemical compoundL-15Invitrogen11415–064
Chemical compoundNerve growth factorInvitrogen13290–010
Chemical compoundNeurobasal A MediumInvitrogen10888–022
Chemical compoundB-27Invitrogen17504–010
Chemical compoundPenicillin-StreptomycinInvitrogen15140–122
Chemical compoundFetal calf serumInvitrogen10082–147
Chemical compoundMinimal Essential MediumAmerican Tissue Type CollectionEMEM 30–2003
Chemical compoundHank's Balanced Salt SolutionGibco14170–112
Chemical compoundDMEM/F12Gibco11330–032
Chemical compoundTetrodotoxin w/citrateAbcamAb120055
Chemical compoundZymosanSigmaZ4250
SoftwareClampexMolecular DevicesVersions 9.2, 10.3.1.5
RRID:SCR_011323
https://www.moleculardevices.com
SoftwareIgor ProWavemetricsVersion 6.12A
RRID:SCR_000325
https://www.wavemetrics.com
SoftwareDataAccessBruxton Corporationhttp://www.bruxton.com/DataAccess/index.html
SoftwareGraphPad PrismGraph PadRRID:SCR_002798Version 5

Additional files

Download links